BioLine RX Ltd Financial Flexibility Index
BioLine RX Ltd financial flexibility index. BioLine RX Ltd (BLRX) has a Financial Flexibility Index of -0.19x as of June 2026. Free cash flow of ILA-3.19 Million (operating CF ILA-3.19 Million minus capex ILA6.24K) represents 0% of total liabilities (ILA16.75 Million). See BLRX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BioLine RX Ltd (2010–2025)
Financial flexibility index of BioLine RX Ltd from 2010 to 2025. Historical Financial Flexibility Index trend for BioLine RX Ltd across 16 annual periods. Check earnings quality score of BioLine RX Ltd to evaluate the quality of earnings relative to operating cash generation.
BioLine RX Ltd Financial Flexibility Index by Year (2010–2025)
BioLine RX Ltd financial flexibility index by year from 2010 to 2025. Year-by-year free cash flow to debt coverage for BioLine RX Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of BioLine RX Ltd.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.50x | ILA-8.71 Million | ILA-8.74 Million | ILA17.56 Million | ▲ +71.2% |
| 2024 | -1.72x | ILA-43.82 Million | ILA-43.87 Million | ILA25.45 Million | ▼ -291.4% |
| 2023 | -0.44x | ILA-22.31 Million | ILA-22.61 Million | ILA50.70 Million | ▲ +56.6% |
| 2022 | -1.01x | ILA-25.92 Million | ILA-26.24 Million | ILA25.54 Million | ▲ +42.5% |
| 2021 | -1.76x | ILA-23.48 Million | ILA-23.57 Million | ILA13.30 Million | ▼ -92.9% |
| 2020 | -0.91x | ILA-23.11 Million | ILA-23.21 Million | ILA25.26 Million | ▲ +18.3% |
| 2019 | -1.12x | ILA-22.59 Million | ILA-22.67 Million | ILA20.19 Million | ▼ -19.4% |
| 2018 | -0.94x | ILA-13.98 Million | ILA-24.19 Million | ILA14.91 Million | ▲ +53.5% |
| 2017 | -2.02x | ILA-16.31 Million | ILA-20.55 Million | ILA8.08 Million | ▲ +45.4% |
| 2016 | -3.70x | ILA-14.46 Million | ILA-14.51 Million | ILA3.91 Million | ▼ -19.2% |
| 2015 | -3.10x | ILA-11.45 Million | ILA-14.17 Million | ILA3.69 Million | ▲ +4.6% |
| 2014 | -3.25x | ILA-14.30 Million | ILA-14.48 Million | ILA4.40 Million | ▼ -33.5% |
| 2013 | -2.43x | ILA-20.12 Million | ILA-20.23 Million | ILA8.27 Million | ▼ -14.0% |
| 2012 | -2.14x | ILA-19.94 Million | ILA-20.11 Million | ILA9.34 Million | ▼ -32.9% |
| 2011 | -1.61x | ILA-10.94 Million | ILA-11.22 Million | ILA6.81 Million | ▼ -400.3% |
| 2010 | 0.54x | ILA12.12 Million | ILA11.46 Million | ILA22.65 Million | — |